Cleared Traditional

K973751 - MT-200

K973751 is an FDA 510(k) clearance for MT-200, manufactured by Schiller America, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 328-day FDA review.

K973751 · Schiller America, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1998
Decision
328d
Days
Class 2
Risk

K973751 is an FDA 510(k) clearance for the MT-200. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Schiller America, Inc. (Tustin, US). The FDA issued a Cleared decision on August 25, 1998 after a review of 328 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Schiller America, Inc. devices

FDA 510(k) Submission Details - K973751

510(k) Number K973751 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 1997
Decision Date August 25, 1998
Days to Decision 328 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
203d slower than avg
Panel avg: 125d · This submission: 328d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 304
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K973751.
SYNEFLASH & SYNEVIEW
K990727 · Ela Medical, Inc. · Nov 1999
CARTO EP NAVIGATION SYSTEM
K992968 · Biosense Webster, Inc. · Sep 1999
CARDIAC DIAGNOSTIC SYSTEM MODEL CH 2000
K983102 · Cambridge Heart, Inc. · Apr 1999
BIOSENSOR HOLTER MONITOR SYSTEM
K974192 · Biosensor Corp. · Mar 1998
BIOSENSOR HOLTER MONITOR SYSTEM
K974546 · Biosensor Corp. · Mar 1998
NIVP3 (WINDOWS VERSION OF NIVP
K970570 · D. E. Hokanson, Inc. · Oct 1997